Myriad Genetics, Inc. (MYGN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -15.7M | 10.6M | 21.1M | -13.6M | -16.3M | 6.6M | 700K | 2.6M | -18.6M | -54.7M | -22.1M | -900K |
| Operating CF Margin % | -7.83% | 5.05% | 10.26% | -6.38% | -8.32% | 3.13% | 0.33% | 1.23% | -9.2% | -27.82% | -11.52% | -0.49% |
| Operating CF Growth % | 3.68% | 60.61% | 2914.29% | -623.08% | 12.37% | 112.07% | 103.17% | 388.89% | 43.98% | -610.39% | -689.29% | 98.19% |
| Net Income | -34.1M | 0 | -27.4M | -330.5M | -100K | -42.5M | -22.1M | -36.7M | -26M | -31.2M | -61.3M | -116.1M |
| Depreciation & Amortization | 12.5M | 0 | 12.6M | 14.1M | 14.4M | 14.8M | 15.6M | 15.1M | 15.7M | 15.1M | 14.1M | 13.3M |
| Stock-Based Compensation | 6.5M | 0 | 12.2M | 10.7M | 9.5M | 10.9M | 12.4M | 14.5M | 12M | 10.4M | 11.6M | 11.2M |
| Deferred Taxes | 0 | 0 | 0 | -200K | -31.3M | 1.5M | -1.1M | -1.9M | 1.2M | -1.7M | -500K | -400K |
| Other Non-Cash Items | -600K | 12.2M | 2.3M | 319.3M | 3.3M | 46.1M | 3.2M | 13.9M | -900K | -6M | 20.5M | -8M |
| Working Capital Changes | 0 | -1.6M | 21.4M | -27M | -12.1M | -24.2M | -7.3M | -2.3M | -20.6M | -41.3M | -6.5M | 99.1M |
| Change in Receivables | 0 | 2.6M | 19M | -16.2M | 800K | 4M | -8.2M | -600K | -3.9M | 17.5M | -3.6M | 7.4M |
| Change in Inventory | 0 | 900K | -2.9M | -300K | -900K | -1.3M | 0 | -3.1M | -1.8M | 3.2M | -2.7M | -600K |
| Change in Payables | 0 | -4.2M | -800K | 3.6M | 0 | -1.1M | -3.6M | 3.3M | 6.1M | -5.9M | -8.5M | 3.1M |
| Cash from Investing | -6.5M | -6M | -6.2M | -6.9M | -8.3M | -5.9M | 7.5M | -6.4M | -7.1M | -12M | -2.5M | 11.8M |
| Capital Expenditures | 0 | -6M | -6.2M | -6.9M | -8.3M | -5.9M | -6.3M | -8.9M | -8.6M | -13.5M | -17.5M | -18.8M |
| CapEx % of Revenue | 2.69% | 2.86% | 3.01% | 3.24% | 4.24% | 2.8% | 2.95% | 4.21% | 4.25% | 6.87% | 9.12% | 10.25% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -6.5M | 0 | 0 | 0 | 0 | 0 | 8.8M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -3M | -8.2M | 56.2M | 2.6M | 13.6M | 2.1M | -3.1M | 2.4M | -8.8M | 121.9M | -2.5M | 38.4M |
| Debt Issued (Net) | 0 | -200K | 64.9M | -100K | 19.4M | 400K | -100K | -100K | -100K | -100K | -100K | 40M |
| Equity Issued (Net) | 0 | 600K | 0 | 2.7M | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -3M | -8.6M | -8.7M | 0 | -5.8M | 1.7M | -3M | 2.5M | -8.7M | 122M | -2.4M | -1.6M |
| Net Change in Cash | -25.3M | -3.5M | 71.1M | -17.3M | -10.9M | 2.1M | 8.6M | -4.4M | -35.3M | 55.9M | -27.7M | 49.6M |
| Free Cash Flow | -21.1M | 5.9M | 14.9M | -20.5M | -24.6M | 700K | -5.6M | -6.3M | -27.2M | -68.2M | -39.6M | -19.7M |
| FCF Margin % | -10.53% | 2.81% | 7.24% | -9.62% | -12.56% | 0.33% | -2.63% | -2.98% | -13.45% | -34.69% | -20.64% | -10.74% |
| FCF Growth % | 14.23% | 742.86% | 366.07% | -225.4% | 9.56% | 101.03% | 85.86% | 68.02% | 52.03% | -205.83% | -93.17% | 65.07% |
| FCF per Share | -0.23 | 0.06 | 0.16 | -0.22 | -0.27 | 0.01 | -0.06 | -0.07 | -0.30 | -0.79 | -0.48 | -0.24 |
| FCF Conversion (FCF/Net Income) | 0.46x | -1.34x | -0.77x | 0.04x | 163.00x | -0.16x | -0.03x | -0.07x | 0.72x | 1.75x | 0.36x | 0.01x |
| Interest Paid | 0 | 0 | 0 | 1.2M | 500K | 0 | 0 | 0 | 0 | 600K | 800K | - |
| Taxes Paid | 0 | 0 | 0 | 0 | 300K | 0 | 0 | 0 | 0 | 600K | 200K | - |